Unknown

Dataset Information

0

Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.


ABSTRACT: Objectives: Clinical trials are currently investigating the safety and efficacy of long-acting injectable (LAI) agents as HIV pre-exposure prophylaxis (PrEP). Using National HIV Behavioral Surveillance data, we assessed the self-reported willingness of men who have sex with men (MSM) to use LAI PrEP and their preference for LAI versus daily oral PrEP.

Methods: In 2014, venue-based sampling was used to recruit MSM aged ?18 years in Washington, DC. Participants completed an interviewer-administered survey followed by voluntary HIV testing. This analysis included MSM who self-reported negative/unknown HIV status at study entry. Correlates of being "very likely" to use LAI PrEP and preferring it to daily oral PrEP were identified using multivariable logistic regression.

Results: Of 314 participants who self-reported negative/unknown HIV status, 50% were <30 years old, 41% were non-Hispanic Black, 37% were non-Hispanic White, and 14% were Hispanic. If LAI PrEP were offered for free or covered by health insurance, 62% were very likely, 25% were somewhat likely, and 12% were unlikely to use it. Regarding preferred PrEP modality, 67% chose LAI PrEP, 24% chose oral PrEP, and 9% chose neither. Correlates of being very likely versus somewhat likely/unlikely to use LAI PrEP included age <30 years (aOR 1.64; 95% CI 1.00-2.68), reporting ?6 (vs. 1) sex partners in the last year (aOR 2.60; 95% CI 1.22-5.53), previous oral PrEP use (aOR 3.67; 95% CI 1.20-11.24), and being newly identified as HIV-infected during study testing (aOR 4.83; 95% CI 1.03-22.67). Black (vs. White) men (aOR 0.48; 95% CI 0.24-0.96) and men with an income of <$20,000 (vs. ?$75,000; aOR 0.37; 95% CI 0.15-0.93) were less likely to prefer LAI to oral PrEP.

Conclusions: If LAI PrEP were found to be efficacious, its addition to the HIV prevention toolkit could facilitate more complete PrEP coverage among MSM at risk for HIV.

SUBMITTER: Levy ME 

PROVIDER: S-EPMC5565177 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.

Levy Matthew E ME   Patrick Rudy R   Gamble Jonjelyn J   Rawls Anthony A   Opoku Jenevieve J   Magnus Manya M   Kharfen Michael M   Greenberg Alan E AE   Kuo Irene I  

PloS one 20170821 8


<h4>Objectives</h4>Clinical trials are currently investigating the safety and efficacy of long-acting injectable (LAI) agents as HIV pre-exposure prophylaxis (PrEP). Using National HIV Behavioral Surveillance data, we assessed the self-reported willingness of men who have sex with men (MSM) to use LAI PrEP and their preference for LAI versus daily oral PrEP.<h4>Methods</h4>In 2014, venue-based sampling was used to recruit MSM aged ≥18 years in Washington, DC. Participants completed an interviewe  ...[more]

Similar Datasets

| S-EPMC6138558 | biostudies-literature
| S-EPMC3316531 | biostudies-other
| S-EPMC7062633 | biostudies-literature
| S-EPMC10439971 | biostudies-literature
| S-EPMC8647505 | biostudies-literature
| S-EPMC7077166 | biostudies-literature
| S-EPMC7869869 | biostudies-literature
| S-EPMC6678719 | biostudies-literature
| S-EPMC10586652 | biostudies-literature
| S-EPMC5851796 | biostudies-literature